New research suggests that patients who discontinue new slimming jabs like Wegovy and Mounjaro tend to recover reduced body mass much more quickly than those who stop conventional diet and exercise regimens.
Research printed in a prominent medical journal demonstrates that while overweight individuals often shed a large proportion of their body weight while undergoing treatment, the mass is regained at an estimated rate of nearly a kilo each month once they quit.
"Individuals using such treatments need to be cognizant of the danger of fast weight regain when the medication is stopped," stated researcher Dr. Susan Jebb.
This pace of recovery suggests a reversion to starting weight in about 18 months.
Weighing Approaches
The analysis, which reviewed dozens of studies involving thousands of participants, compared the outcomes of the injectable medications with older methods.
Researchers emphasize that people who shed pounds through dieting generally see a slower creep back—approximately 100 grams monthly—post-intervention.
The Reason for the Quick Regain
Doctors propose the mode of action of the jabs explains the amplified regain.
The injections copy a body's own chemical called GLP-1, which moderates feelings of fullness.
"Artificially providing GLP-1 levels several times higher than the body's typical production might result in the body to produce less of its own natural hormone, and could lessen sensitivity to its actions," said Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this GLP-1 'fix' means hunger is unsuppressed, making binge eating far more likely."
An Ongoing Condition?
Medical guidelines advise the jabs for individuals with weight-linked health risks, alongside prescribed lifestyle changes.
A number of clinicians argue that, due to the high risk of weight regain, the treatment is often life-long.
This view is supported by drug manufacturers, who state that the results "underscore the chronic character of obesity," akin to managing diseases like high blood pressure.
Patient Experiences
Individuals who have discontinued the medication explain a intense return of hunger.
"It felt as if something that goes on and you become extremely hungry," described a patient.
The struggle is worsened if individuals have not adopted lasting dietary or behavioural changes during treatment.
Growing Use
Recent estimates show that millions of adults in the UK have tried these injections in the last 12 months, with interest continuing to grow.
- Use is greater among females than males.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion access the medications through private healthcare rather than public health services.
In conclusion, researchers caution that while the jabs are potent tools for weight loss, they are not a magic solution and long-term success hinges on ongoing lifestyle management.
